SNU13

Across TCGA pan-cancer cohorts, SNU13 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of SNU13’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SNU13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNU13 is over-expressed in tumor, although a few such as KICH and KIRC show the opposite, repressed pattern.

COAD, LIHC, and HNSC are the cancer types where SNU13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNU13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.867	<.001	11	view →
LIHC	Female	II,III,IV	+1.185	<.001	9	view →
HNSC	Male	III,IV	+0.697	<.001	8	view →
LUSC	Female	All	+0.486	<.001	8	view →
STAD	All	II,III,IV	+0.544	<.001	7	view →
CHOL	Male	All	+2.310	<.001	5	view →
KICH	Female	All	−0.848	<.001	5	view →
READ	All	All	+0.519	.002	3	view →
KIRC	All	II,III,IV	−0.226	.006	3	view →
ESCA	All	All	+0.716	.007	2	view →
KIRP	All	IV	+0.522	.046	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

SNU13–COAD

Open the COAD breakdown →